C. Conejero

Positive impact of molecular analysis on prognostic scores in essential thrombocythemia: a single center prospective cohort experience

V. Ugo, L. Roy, S. Giraudier, 2018, Haematologica.

Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders

P. Fenaux, B. Grandchamp, G. Hetet, 2006, Leukemia.

Unexplained thrombocytosis: association of Baltimore polymorphism with germline MPL nonsense mutation

C. Chomienne, S. Giraudier, B. Cassinat, 2016, British journal of haematology.

Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study

M. Béné, V. Ugo, E. Lippert, 2018, American journal of hematology.

Emergence of MPLW515 mutation in a patient with CALR deletion: Evidence of secondary acquisition of MPL mutation in the CALR clone

M. Tulliez, C. Cordonnier, S. Giraudier, 2018, Hematological oncology.

Analysis of JAK2 Mutation in Essential Thrombocythemia (ET) Patients with Monoclonal and Polyclonal X-Chromosome Inactivation Patterns (XCIPs).

P. Fenaux, B. Grandchamp, C. Gardin, 2005 .